feed on feeds - 2015/01/07 - items 0 to 15

Tre personer uppges ha gripits för del i den blodiga attacken mot satirtidningen Charlie Hebdos redaktion i Paris där tolv personer sköts ihjäl, men uppgiften har inte bekräftats.

Tre unga män tros vara identifierade som skyldiga till den blodiga attacken mot satirtidningen Charlie Hebdos redaktion i Paris där tolv personer sköts ihjäl. En talesman för franska polisen säger till The Guardians korrespondent att tre personer gripits, misstänkta för del i attacken.

EU:s utrikesministrar kommer att diskutera kampen mot terrorism vid sitt nästa möte, efter attacken mot Charlie Hebdo i Paris.

En ”feg och ondskefull” attack, det säger USA:s president Barack Obama som fördömer dådet mot den franska satirtidningen Charlie Hebdo.

Fem personer, en med ett föremål som liknade en pistol, kom in på en hårsalong i Rågsved i södra Stockholm och krävde en större summa pengar på onsdagskvällen. En förundersökning om grov utpressning är inledd.

sciencehabit writes For much of the last decade, a team of researchers in Boston has eagerly exhumed and reburied dirt. It's part of a strategy to access an untapped source of new antibiotics—the estimated 99% of microbes in the environment that refuse to grow in laboratories. Now, their technique has yielded a promising lead: a previously unknown bacterium that makes a compound with infection-killing abilities. What's more, the team claims in a report out today, the compound is unlikely to fall prey to the problem of antibiotic resistance. That suggestion has its skeptics, but if the drug makes it through clinical trials, it would be a much needed weapon against several increasingly hard-to-treat infections.

Read more of this story at Slashdot.

sciencehabit writes For much of the last decade, a team of researchers in Boston has eagerly exhumed and reburied dirt. It's part of a strategy to access an untapped source of new antibiotics—the estimated 99% of microbes in the environment that refuse to grow in laboratories. Now, their technique has yielded a promising lead: a previously unknown bacterium that makes a compound with infection-killing abilities. What's more, the team claims in a report out today, the compound is unlikely to fall prey to the problem of antibiotic resistance. That suggestion has its skeptics, but if the drug makes it through clinical trials, it would be a much needed weapon against several increasingly hard-to-treat infections.